Biosintesis

R&D

RESEARCH & DEVELOPMENT

“Invention is the creation of something new, innovation is the creation of something new that bring results”

 

The main function of a group of R&D is to develop new products or to discover and create new knowledge on scientific and technological topics, allowing the development of new products, processes and services. Based on this premise Biosintesis aggregates the development of new knowledge bringing to Brazilian market the best and most innovative worldwide techniques in the areas of biological studies in addition to evaluation of new molecules and materials, such as:

 

  • Bioresorbable polymers
  • Evaluation of new molecules for cosmetics and pharmaceuticals
  • Evaluation of new materials for medical devices and biomaterials
  • Biocompatibility (implants, cardiovascular devices, etc.)

 

THE BIOSINTESIS DISTINGUISHES ITSELF BY THE RESEARCH PROJECTS, DEVELOPMENT AND INNOVATION

 

  • Standardization of toxicological assays, according to principles of Good Laboratorial Practice (GLP)
    • Process: 50507/2004-5, CNPq edict
  • Development, preclinical study and biocompatibility of implantable devices
    • Process: 06/56731-0, edict FAPESP/PIPE, 557995/2008-6, edict CNPq, 1907/09, edict FINEP grant
  • Development of preclinical studies for hemocompatibility in the evaluation of medical devices in cardiovascular applications and orthopedic implants
    • Process: 573362/2008-4, CNPq
  • Standardization, development and preclinical study of security and efficacy of radiopharmaceuticals.
    • Process: DIRF DPDE 2008, Board of Radiopharmacy of IPEN
  • Toxicity of nanoparticles in biological system: study of interactions of nanoparticles with cells and tissues
    • Process: 552135/2011-9, Inmetro / CNPq